In recent developments, Repligen (RGEN, Financial) has been the subject of a new stock analysis by Stephens & Co., a reputable financial services firm. Analyst Steven Etoch has given this stock an "Overweight" rating, indicating a positive outlook on the company's performance.
This rating comes with an announced price target of $160.00 USD. Previously, no specific target price had been set for Repligen, making this a notable update in the stock's valuation outlook.
The "Overweight" rating suggests that Repligen (RGEN, Financial) is expected to perform better than the average market return according to the analyst's insights. Investors are advised to consider this information when making investment decisions, as it reflects Stephens & Co.'s confidence in Repligen's growth prospects.
Repligen (RGEN, Financial) continues to trade on the NASDAQ, and the latest updates on its stock performance are crucial for stakeholders and market watchers interested in the company's financial trajectory. The date of this announcement is July 22, 2025, providing a current and up-to-date perspective on Repligen's market position.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Repligen Corp (RGEN, Financial) is $181.01 with a high estimate of $220.00 and a low estimate of $130.00. The average target implies an upside of 59.72% from the current price of $113.33. More detailed estimate data can be found on the Repligen Corp (RGEN) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, Repligen Corp's (RGEN, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Repligen Corp (RGEN, Financial) in one year is $178.65, suggesting a upside of 57.64% from the current price of $113.33. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Repligen Corp (RGEN) Summary page.
